Skip to main content
Caplight Logo









BRC Therapeutics

BRC Therapeutics

Private
Castroville, CaliforniaHealthcare & Life Scienceshttps://brctherapeutics.com/

Last Round

Series A

Oct 4, 2022

Total Funding Raised

$23M

Company Overview

BRC Therapeutics is a biopharmaceutical company that develops cannabinoid-based prescription medicines for the treatment of pain and neurological conditions.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Clinical Trials, Pharma Supply Chain, Compliance

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

cannabis researchDEA-compliant cannabiscannabinoid therapeuticsclinical trial supplyresearch-grade cannabiscannabis supply chainanalytical testingcGMP manufacturingregulatory compliancecontrolled substancesweed researchcannabis pharmadrug developmentterpene profilingcannabinoid profiling

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BRC Therapeutics Comparables

Compare BRC Therapeutics with similar companies based on industry and business-model similarity.

BRC Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Groff North America
84%
Maridose LLC
83%
Royal Emerald Pharmaceuticals
80%

BRC Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AOct 4, 2022
Convertible DebtOct 2, 2020

BRC Therapeutics Investors

Notable investors and investment history

BRC Therapeutics investors
InvestorRounds
Achari VenturesSeries A
Intrinsic Capital PartnersSeries A
Delta Emerald VenturesSeries A
AFI Capital PartnersSeries A
Argonautic VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 14, 2025

    Dr. Stephen Wright joins as Advisor in Drug Development.

  • Oct 4, 2022

    $20M round led by Intrinsic Capital Partners.

BRC Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

BRC Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about BRC Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersCastroville, California
Employee Range17
Year Founded2017
Last FundingOct 4, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?